MHR
Matthew Hamilton Rosenberg’s Gilead Sciences GILD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $280K | Buy |
2,522
+304
| +14% | +$33.7K | 0.07% | 154 |
|
|
2025
Q1 | $249K | Hold |
2,218
| – | – | 0.06% | 155 |
|
|
2024
Q4 | $205K | Buy |
2,218
+50
| +2% | +$4.62K | 0.05% | 176 |
|
|
2024
Q3 | $182K | Hold |
2,168
| – | – | 0.05% | 206 |
|
|
2024
Q2 | $149K | Hold |
2,168
| – | – | 0.04% | 226 |
|
|
2024
Q1 | $158K | Buy |
2,168
+57
| +3% | +$4.16K | 0.05% | 227 |
|
|
2023
Q4 | $171K | Sell |
2,111
-39
| -2% | -$3.16K | 0.05% | 209 |
|
|
2023
Q3 | $161K | Buy |
2,150
+56
| +3% | +$4.2K | 0.05% | 205 |
|
|
2023
Q2 | $161K | Buy |
2,094
+42
| +2% | +$3.24K | 0.05% | 210 |
|
|
2023
Q1 | $170K | Buy |
2,052
+1
| +0% | +$83 | 0.05% | 212 |
|
|
2022
Q4 | $176K | Buy |
2,051
+66
| +3% | +$5.67K | 0.06% | 200 |
|
|
2022
Q3 | $122K | Buy |
1,985
+53
| +3% | +$3.26K | 0.05% | 247 |
|
|
2022
Q2 | $120K | Buy |
1,932
+71
| +4% | +$4.41K | 0.05% | 263 |
|
|
2022
Q1 | $111K | Buy |
1,861
+1,225
| +193% | +$73.1K | 0.04% | 286 |
|
|
2021
Q4 | $46K | Sell |
636
-236
| -27% | -$17.1K | 0.02% | 426 |
|
|
2021
Q3 | $61K | Buy |
872
+348
| +66% | +$24.3K | 0.02% | 363 |
|
|
2021
Q2 | $36K | Sell |
524
-61
| -10% | -$4.19K | 0.02% | 407 |
|
|
2021
Q1 | $28K | Buy |
585
+156
| +36% | +$7.47K | 0.02% | 404 |
|
|
2020
Q4 | $25K | Sell |
429
-1,349
| -76% | -$78.6K | 0.02% | 403 |
|
|
2020
Q3 | $112K | Sell |
1,778
-947
| -35% | -$59.7K | 0.08% | 181 |
|
|
2020
Q2 | $210K | Buy |
2,725
+584
| +27% | +$45K | 0.17% | 77 |
|
|
2020
Q1 | $161K | Buy |
+2,141
| New | +$161K | 0.16% | 69 |
|